US OptionsDetailed Quotes
UPXI250221C2500
- 0.05
- 0.000.00%
15min DelayClose Oct 2 16:00 ET
0.00High0.00Low
0.00Open0.05Pre Close0 Volume34 Open Interest2.50Strike Price0.00Turnover0.00%IV-35.44%PremiumFeb 21, 2025Expiry Date1.45Intrinsic Value100Multiplier60DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma79.00Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Upexi Stock Discussion
👀
$Poseida Therapeutics (PSTX.US)$ ✔️TOP PLAY. To be acquired by Roche for $1.5B for $9.00/share. “Poseida stockholders to receive up to $13.00 per share in cash, comprised of $9.00 per share in cash at closing and a non-tradeable contingent value right (CVR) to receive up to an aggregate of $4.00 per share in cash”
$Citius Pharmaceuticals (CTXR.US)$✔️ News halt after hours + PR today o...
📊⚡️📊
📊⚡️📊
No comment yet